TNF-α-IN-31
TNF-α-IN-31 is an orally active TNF-α inhibitor. TNF-α-IN-31 binds to the distal C-lobe site of MKK3 in a non-ATP-competitive manner (Kd = 3.35 nM; IC50 > 10 μM), selectively inhibiting the TAK1/MKK3/p38 axis with negligible effect on ERK and JNK phosphorylation. TNF-α-IN-31 can be used for research on ulcerative colitis.
For research use only. We do not sell to patients.
- CAS No.: 3122437-76-4
- Formula: C23H25NO6
- Molecular Weight:411.45
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
TAK1 |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| RAW264.7 | IC50 |
0.038 μM
|
Inhibition of TNF-α production in LPS-stimulated RAW264.7 macrophages pretreated for 1 h and stimulated with 1 μg/mL LPS for 7 h, measured by RT-qPCR.
Inhibition of TNF-α production in LPS-stimulated RAW264.7 macrophages pretreated for 1 h and stimulated with 1 μg/mL LPS for 7 h, measured by RT-qPCR.
|
5454671 |
| RAW264.7 | CC50 |
100 μM
|
Cytotoxicity against RAW264.7 macrophages assessed as viability reduction after 24 h incubation by CCK-8 assay with CC50 >100 μM.
Cytotoxicity against RAW264.7 macrophages assessed as viability reduction after 24 h incubation by CCK-8 assay with CC50 >100 μM.
|
5454671 |
In Vitro
TNF-α-IN-31 (6.25 µM; 24 h; heating at 38-53 °C for 3 min) binds to MKK3 in RAW264.7 cells, increasing the thermal stability of MKK3 from 45 °C to 50 °C[1].
TNF-α-IN-31 selectively inhibits p38 phosphorylation in LPS-induced RAW264.7 cells without affecting ERK or JNK phosphorylation[1].
TNF-α-IN-31 shows no catalytic activity against MKK3 in the ADP-Glo assay (IC50 >10 µM)[1].
TNF-α-IN-31 (10 µM) shows a favorable kinome selectivity profile, with inhibition rates of <25% against all 81 kinases[1].
The mouse plasma protein binding rate of TNF-α-IN-31 is 55.03%[1].
TNF-α-IN-31 (10 µM) shows minimal inhibition of CYP2C9/2D6/3A4[1].
hERG IC50 of TNF-α-IN-31 is >40 µM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:LPS-stimulated RAW264.7 macrophages
-
Concentration:0.20, 0.39, 0.78, 1.56, 3.13, 6.25 µM
-
Incubation Time:1 h pretreatment and 7 h LPS stimulation
-
Result:TNF-α inhibition IC50 was 0.038 µM.
-
Cell Line:RAW264.7 macrophages
-
Concentration:100, 50, 25, 12.5, 6.25, 3.13, 1.56 µM
-
Incubation Time:24 h incubation, then 1 h CCK-8
-
Result:CC50 was >100 µM.
In Vivo
(R)-48 (1-3 mg/kg; p.o.; once daily; 5 days) produces dose-dependent improvements in DAI, colonic ulceration, colon weight/length recovery, and histopathological recovery in TNBS-induced acute UC[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6 (male, 8 weeks old)[1]
-
Dosage:1 mg/kg/day; 3 mg/kg/day; 10 mg/kg/day
-
Administration:i.g.; once daily; 9 days
-
Result:Colon length recovery ratio was 10.9% at 1 mg/kg/day, 18.5% at 3 mg/kg/day, and 23.4% at 10 mg/kg/day.
DAI recovery ratio was 0.0% at 1 mg/kg/day, 8.3% at 3 mg/kg/day, and 12.5% at 10 mg/kg/day.
Histopathological score recovery ratio was 36.3% at 1 mg/kg/day, 41.7% at 3 mg/kg/day, and 64.6% at 10 mg/kg/day.
Serum cytokine reductions at 1/3/10 mg/kg/day were: TNF-α 27.1%/55.0%/76.1%; IL-1β 5.1%/46.2%/61.0%; IL-6 41.4%/70.2%/74.6%; IL-23 39.0%/55.7%/67.6%.
Colonic mRNA expression reductions at 1/3/10 mg/kg/day were: TNF-α 34.8%/64.6%/68.1%; IL-1β −12.2%/40.9%/53.5%; IL-6 21.3%/56.6%/66.4%; IL-23 15.7%/41.7%/53.4%.
-
Animal Model:C57BL/6 (male, 6-8 weeks old)[1]
-
Dosage:1 mg/kg/day; 3 mg/kg/day
-
Administration:p.o.; once daily; 5 days
-
Result:DAI recovery ratio was 9.1% at 1 mg/kg/day and 18.2% at 3 mg/kg/day.
Colon ulcer recovery ratio was 27.9% at 1 mg/kg/day and 34.6% at 3 mg/kg/day.
Colon weight/length recovery ratio was 64.3% at 1 mg/kg/day and 70.7% at 3 mg/kg/day.
Histopathological score recovery ratio was 15.0% at 1 mg/kg/day and 45.0% at 3 mg/kg/day.
Parmacokinetics
Chemical Information
-
CAS No. 3122437-76-4
-
Molecular Weight 411.45
-
Formula C23H25NO6
-
SMILES
O=C1N(C2=CC=C([C@H]3CC(C4=C3C(OC)=CC(OCCOC)=C4)=O)C=C2)CCOC1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)